Cargando…
Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646105/ http://dx.doi.org/10.1186/2051-1426-3-S2-P62 |
| _version_ | 1782400915537395712 |
|---|---|
| author | Zhang, Xiaokui Kang, Lin Djuretic, Ivana Law, Eric Voskinarian-Berse, Vanessa Harris, Jeffrey Herzberg, Uri Hofgartner, Wolfgang Hariri, Robert |
| author_facet | Zhang, Xiaokui Kang, Lin Djuretic, Ivana Law, Eric Voskinarian-Berse, Vanessa Harris, Jeffrey Herzberg, Uri Hofgartner, Wolfgang Hariri, Robert |
| author_sort | Zhang, Xiaokui |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4646105 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46461052015-11-20 Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy Zhang, Xiaokui Kang, Lin Djuretic, Ivana Law, Eric Voskinarian-Berse, Vanessa Harris, Jeffrey Herzberg, Uri Hofgartner, Wolfgang Hariri, Robert J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646105/ http://dx.doi.org/10.1186/2051-1426-3-S2-P62 Text en Copyright © 2015 Zhang et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Zhang, Xiaokui Kang, Lin Djuretic, Ivana Law, Eric Voskinarian-Berse, Vanessa Harris, Jeffrey Herzberg, Uri Hofgartner, Wolfgang Hariri, Robert Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy |
| title | Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy |
| title_full | Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy |
| title_fullStr | Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy |
| title_full_unstemmed | Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy |
| title_short | Potent ex vivo expanded, human CD34+ cord blood-derived natural killer cells for cancer immunotherapy |
| title_sort | potent ex vivo expanded, human cd34+ cord blood-derived natural killer cells for cancer immunotherapy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646105/ http://dx.doi.org/10.1186/2051-1426-3-S2-P62 |
| work_keys_str_mv | AT zhangxiaokui potentexvivoexpandedhumancd34cordbloodderivednaturalkillercellsforcancerimmunotherapy AT kanglin potentexvivoexpandedhumancd34cordbloodderivednaturalkillercellsforcancerimmunotherapy AT djureticivana potentexvivoexpandedhumancd34cordbloodderivednaturalkillercellsforcancerimmunotherapy AT laweric potentexvivoexpandedhumancd34cordbloodderivednaturalkillercellsforcancerimmunotherapy AT voskinarianbersevanessa potentexvivoexpandedhumancd34cordbloodderivednaturalkillercellsforcancerimmunotherapy AT harrisjeffrey potentexvivoexpandedhumancd34cordbloodderivednaturalkillercellsforcancerimmunotherapy AT herzberguri potentexvivoexpandedhumancd34cordbloodderivednaturalkillercellsforcancerimmunotherapy AT hofgartnerwolfgang potentexvivoexpandedhumancd34cordbloodderivednaturalkillercellsforcancerimmunotherapy AT haririrobert potentexvivoexpandedhumancd34cordbloodderivednaturalkillercellsforcancerimmunotherapy |